Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.50 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.32 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | CHAT | P28329 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13420617 | 0.94 | FUT8 (0.49) | FUT8CARM1PRMT1ENPP2CYP1A2 | |
| SCHEMBL13599496 | 0.86 | FUT8 (0.48) | FUT8CARM1PRMT1ENPP2CA9 | |
| SCHEMBL14012420 | 0.85 | FUT8 (0.43) | FUT8CARM1PRMT1ENPP2THRB | |
| SCHEMBL13599491 | 0.83 | FUT8 (0.46) | FUT8CARM1PRMT1ENPP2CA9 | |
| SCHEMBL13599484 | 0.83 | FUT8 (0.52) | FUT8CARM1PRMT1ENPP2CYP1A2 | |
| SCHEMBL14582560 | 0.81 | FUT8 (0.49) | FUT8ENPP2 | |
| SCHEMBL14585720 | 0.81 | FUT8 (0.46) | FUT8CARM1PRMT1ENPP2CA9 | |
| SCHEMBL13839143 | 0.79 | FUT8 (0.51) | FUT8PRMT1ENPP2CYP1A2CYP2C9 | |
| SCHEMBL13599478 | 0.79 | FUT8 (0.49) | FUT8CARM1PRMT1ENPP2CYP1A2 | |
| SCHEMBL14585721 | 0.79 | FUT8 (0.49) | FUT8CARM1PRMT1ENPP2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683208-B2 | Bridge compound with N,N-dialkylamino group and application thereof | EVERLIGHT USA, INC. (US) | 2010-03-23 | — | — | US | disclosed |
| US-20090054645-A1 | Bridge compound with N, N-dialkylamino group and application thereof | EVERLIGHT USA, INC. (US) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054645-A1 | Bridge compound with N, N-dialkylamino group and application thereof | ALKBH1, ALKBH2, B2M | FUT8 886/4885CARM1 421/4885PRMT1 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.